 |
|
Comparison between obese and non-obese nonalcoholic fatty liver disease
Wah-Kheong Chan
Clin Mol Hepatol. 2023;29(Suppl):S58-S67. Published online 2022 Dec 5 DOI: https://doi.org/10.3350/cmh.2022.0350
|
|
Citations to this article as recorded by
 Optimal BMI cutoff for lean MASLD/MetALD and adverse hepatic outcomes in East-Asian populations
Byungyoon Yun, Juyeon Oh, Heejoo Park, Beom Kyung Kim, Jin-Ha Yoon
European Journal of Internal Medicine.2025;[Epub] CrossRef Impact of nonalcoholic fatty liver disease on the risk of gallbladder polyps in lean and non-obese individuals: A cohort study
Nam Hee Kim, Ji Hun Kang, Hong Joo Kim
Hepatobiliary & Pancreatic Diseases International.2024; 23(6): 573. CrossRef Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study
Changhui Yu, Shiming He, Maobin Kuang, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou
BMC Endocrine Disorders.2024;[Epub] CrossRef Triglycerides Mediate the Influence of Body Mass Index on Non-Alcoholic Fatty Liver Disease in a Non-Obese Chinese Population with Normal Low-Density Lipoprotein Cholesterol Levels
Xixi Han, Jingwen Kong, Hemin Zhang, Yuan Zhao, Yafeng Zheng, Chao Wei
Obesity Facts.2024; 17(2): 191. CrossRef Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort
Huiyul Park, Eileen L. Yoon, Goh Eun Chung, Eun Kyung Choe, Jung Ho Bae, Seung Ho Choi, Mimi Kim, Woochang Hwang, Hye-Lin Kim, Sun Young Yang, Dae Won Jun
Gut and Liver.2024; 18(2): 316. CrossRef Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals
Nam Hee Kim, Ji Hun Kang, Hong Joo Kim
European Journal of Gastroenterology & Hepatology.2024; 36(7): 945. CrossRef Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping
Shahid Habib
World Journal of Gastrointestinal Pathophysiology.2024;[Epub] CrossRef Cardiometabolic and Metabolic Profiles of Lean/Normal, Overweight and Obese Patients with Nonalcoholic Fatty Liver Disease
Siyao Wang, Yong Zhang, Xiaoya Qi, Xiaoyang Xu
Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2027. CrossRef Association between the cardiometabolic index and NAFLD and fibrosis
Laisha Yan, Xiaoyan Hu, Shanshan Wu, Can Cui, Shunying Zhao
Scientific Reports.2024;[Epub] CrossRef Predictive Value of the Chinese Visceral Adiposity Index for Metabolic Dysfunction-Associated Fatty Liver Disease and Elevated Alanine Aminotransferase Levels in Nonobese Chinese Adults: A Cross-Sectional Study
Zuohu Niu, Jialiang Chen, Huijing Wang, Rongrui Wang, Hongye Peng, Shaojie Duan, Shukun Yao
Journal of Inflammation Research.2024; Volume 17: 3893. CrossRef From MASLD to HCC: What's in the middle?
Alessia Provera, Cristina Vecchio, Anteneh Nigussie Sheferaw, Ian Stoppa, Deepika Pantham, Umberto Dianzani, Salvatore Sutti
Heliyon.2024; 10(15): e35338. CrossRef Mitigating Effects of Tanacetum balsamita L. on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Rositsa Mihaylova, Reneta Gevrenova, Alexandra Petrova, Yonko Savov, Dimitrina Zheleva-Dimitrova, Vessela Balabanova, Georgi Momekov, Rumyana Simeonova
Plants.2024; 13(15): 2086. CrossRef Comparison of Risk Factors Between Lean and Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals With Type 2 Diabetes: A Multicenter Study
Weixia Sun, Yingqi Lv, Li Wang, Hekai Yu, He Yi, Yifan Wang, Jing Han, Yingzhao Liu, Congqing Miao, Jie Li, Yan Zhang, Mengying Wang, Lei Chen, Stephen J. Pandol, Ling Li
Endocrine Practice.2024; 30(12): 1171. CrossRef Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South Asians
Margeyi Mehta, Jigish Shah, Urvish Joshi
Cureus.2024;[Epub] CrossRef Liver Fibrosis in Some Patients with Non-Alcoholic Fatty Liver Disease: from Diagnosis to Prognosis
Tatyana S. Krolevets, Maria A. Livzan, Maria I. Syrovenko
Annals of the Russian academy of medical sciences.2024; 79(4): 293. CrossRef Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal study
Jaejun Lee, Jinson So, Chang In Han, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Do Seon Song
Hepatology International.2024;[Epub] CrossRef Correspondence to editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
Hayeon Kim, Min Jeong Park, Myeong Gyu Kim, Kyungim Kim
Clinical and Molecular Hepatology.2024; 30(4): 989. CrossRef An overview of pathogenesis of metabolic dysfunction-associated steatotic liver disease
Shahid Habib, Andrew Johnson
Exploration of Digestive Diseases.2024; : 459. CrossRef Lactobacillus plantarum L11 and Lactobacillus reuteri LR: Ameliorate Obesity via AMPK Pathway
Shukun Liang, Jintao Sun, Xinshu Gu, Ya Zhao, Xiumin Wang, Hui Tao, Zhenlong Wang, Yougang Zhong, Jinquan Wang, Bing Han
Nutrients.2024; 17(1): 4. CrossRef Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Ho Soo Chun, Minjong Lee
Clinical and Molecular Hepatology.2023; 29(2): 377. CrossRef Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy
Wah-Loong Chan, Shi-En Chong, Felicia Chang, Lee-Lee Lai, Kee-Huat Chuah, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Wah-Kheong Chan
Hepatology International.2023; 17(4): 870. CrossRef Food Network Analysis in Non-Obese Patients with or without Steatosis
Rossella Donghia, Pasqua Letizia Pesole, Sergio Coletta, Caterina Bonfiglio, Giovanni De Pergola, Sara De Nucci, Roberta Rinaldi, Gianluigi Giannelli
Nutrients.2023; 15(12): 2713. CrossRef Response to letter to editor: Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B
Yong‐Wen Leow, Wah‐Kheong Chan
Journal of Viral Hepatitis.2023; 30(8): 712. CrossRef Visceral fat: A key mediator of NAFLD development and progression
Savita Bansal, Meenakshi Vachher, Taruna Arora, Bhupender Kumar, Archana Burman
Human Nutrition & Metabolism.2023; 33: 200210. CrossRef Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan
Medicina.2023; 59(9): 1614. CrossRef Zebrafish as a Useful Model System for Human Liver Disease
Nobuyuki Shimizu, Hiroshi Shiraishi, Toshikatsu Hanada
Cells.2023; 12(18): 2246. CrossRef Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
Eugene Han, Yong-ho Lee
Clinical and Molecular Hepatology.2023; 29(4): 980. CrossRef Associations of Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease With Cardiovascular Healthy Outcomes
Wentao Wu, Wen Ma, Shiqi Yuan, Aozi Feng, Li Li, Haoxiao Zheng, Shuna Li, Ningxia He, Yuli Huang, Jun Lyu
Journal of the American Heart Association.2023;[Epub] CrossRef
|